AURORA 1 reports efficacy of voclosporin in lupus nephritis

被引：2
|
作者：
Moroni, Gabriella [1 ,2 ]
Ponticelli, Claudio [3 ]
机构：
[1] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[2] IRCCS Humanitas Res Hosp, Milan, Italy
[3] IRCCS Osped Maggiore Policlin, Nephrol, Milan, Italy
来源：
NATURE REVIEWS NEPHROLOGY | 2021年 / 17卷 / 10期
关键词：
CYCLOSPORINE;
D O I：
10.1038/s41581-021-00460-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The AURORA 1 study reports that low-dose voclosporin added to standard immunosuppressive treatment improved rate of remission in patients with lupus nephritis. Further studies are needed to investigate the long-term efficacy and tolerability of voclosporin and to compare the effects of this treatment with those of low doses of tacrolimus or ciclosporin.
引用
收藏
页码：637 / 638
页数：2
相关论文
共 50 条
  • [41] Comparison of Dual-immunosuppressive Therapy with a Voclosporin-based, Triple-immunosuppressive Regimen for Lupus Nephritis in the ALMS and AURORA 1 Studies
    Dall'Era, Maria
    Yap, Ernie
    Truman, Matt
    Hodge, Lucy
    Solomons, Neil
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1571 - 1573
  • [42] 48 WEEK COMPLETE REMISSION OF ACTIVE LUPUS NEPHRITIS WITH VOCLOSPORIN
    Dobronravov, V.
    Dooley, M. A.
    Haq, S. A.
    Adzerikho, I.
    Bugrova, O.
    Isenberg, D.
    Houssiau, F.
    Solomons, N.
    Huizinga, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 153 - 153
  • [43] VICTORY WITH VOCLOSPORIN: A CASE OF COMPLETE REMISSION IN SEVERE LUPUS NEPHRITIS
    Tullis, Erin
    Edwards, Angelina
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S49 - S49
  • [44] EARLY REDUCTIONS IN PROTEINURIA WITH VOCLOSPORIN TREATMENT ACROSS LUPUS NEPHRITIS BIOPSY CLASSES: POOLED DATA FROM THE AURA-LV AND AURORA 1 TRIALS
    Askanase, Anca
    Hodge, Lucy
    Birardi, Vanessa
    Leher, Henry
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I820 - I822
  • [45] Voclosporin in der Therapie der LupusnephritisVoclosporin for the treatment of lupus nephritis
    Sebastian Dolff
    Die Nephrologie, 2022, 17 : 334 - 338
  • [46] B-cell depletion or belimumab or voclosporin for lupus nephritis?
    Lei, Yutian
    Loutan, Jerome
    Anders, Hans-Joachim
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2021, 30 (02): : 237 - 244
  • [47] SUCCESSFUL TREATMENT OF LUPUS NEPHRITIS WITH BELIMUMAB AND VOCLOSPORIN: A RARE CASE
    Ebrahimi, Niloufar
    Ghozloujeh, Zohreh Gholizadeh
    Momand, David
    Abdipour, Amir
    Norouzi, Sayna
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S16 - S16
  • [48] Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study
    Saxena, Amit
    Caster, Dawn
    Almaani, Salem
    Rosales, Amber
    Leher, Henry
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 704 - 706
  • [49] Long-Term Use of Voclosporin in Patients With Class V Lupus Nephritis: Results From the AURORA 2 Continuation Study
    Caster, Dawn J.
    Saxena, Amit
    Almaani, Salem
    Rosales, Amber
    Leher, Henry
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 498 - 498
  • [50] Early Reductions in Proteinuria with Voclosporin Treatment Across Lupus Nephritis Biopsy Classes: Pooled Data from the AURA-LV and AURORA 1 Trials
    Askanase, Anca
    Hodge, Lucy
    Birardi, Vanessa
    Leher, Henry
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 706 - 708
12345